Source and scope
This summary is bounded to the recommendations, population and decisions covered by Using Antibiotics Wisely in primary care. Apply it with the current provincial or territorial pathway where implementation differs.
sources for this section:CWC antibiotics
Source-attributed clinical priorities
- Confirm acute middle-ear inflammation with appropriate otoscopy rather than diagnosing from ear pain or a red tympanic membrane alone.
- Use analgesia and, for eligible children, watchful waiting with reliable follow-up instead of automatic antibiotics.
- Treat severe illness, high-risk age or complications according to provincial pediatric guidance and local resistance patterns.
- Middle-ear effusion without acute inflammatory symptoms is not acute otitis media and does not require antibiotics.
sources for this section:CWC antibiotics
Practical assessment and management workflow
1
Control cerumen and inspect tympanic-membrane position, mobility, opacity and perforation.
2
Record age, severity, laterality, duration, recurrence and reliable follow-up.
3
Use analgesia first and offer observation when the child meets Canadian watchful-waiting criteria.
4
Review persistent effusion for hearing, speech and developmental impact rather than extending antibiotics.
sources for this section:CWC antibiotics
Safety, red flags and urgent escalation
- Escalate postauricular swelling, pinna displacement, facial weakness or systemic toxicity for mastoiditis assessment.
- Very young or immunocompromised children and those with craniofacial risk need individualized management.
- Avoid topical ototoxic drops through a non-intact tympanic membrane unless specifically indicated.
sources for this section:CWC antibiotics
Confirm the local pathway before acting
The evidence source is pan-Canadian, but formularies, funded access, referral routes, public-health directions and service availability remain provincial or territorial.
sources for this section:CWC antibiotics
Source and implementation boundary
Read this educational summary with the linked source, current Canadian product information where medicines are involved, and the applicable provincial or territorial pathway. Local formularies, reporting duties, referral routes and service availability can differ.
sources for this section:CWC antibiotics
Source documents
Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.
- Choosing Wisely CanadaUsing Antibiotics Wisely in primary careaccessed 2026-08-20view source
continue the learning
From guidance to deliberate practice and evidence
Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.
Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the Canada question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.